Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAPA-MODA: Dapagliflozin for Cardiac Remodeling in Heart Failure
NCT04707352Phase 3Completed
- Sponsor
- Fundación para la Formación e Investigación Sanitaria
- Start
- Feb 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dapagliflozin in heart failure (HF), sponsored by Fundación para la Formación e Investigación Sanitaria. Started Feb 2021; status: completed.
02
Drugs
dapagliflozin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04707352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04707352.